Odyssey Evaluation in Post LASIK Patients
ConditionCataract
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age50+
SponsorCenter For Sight
About this trial
This prospective study evaluates the visual and refractive outcomes of the TECNIS Odyssey intraocular lens (IOL) implanted in patients with a history of myopic LASIK. Given the unique optical challenges of post-LASIK eyes, including altered corneal curvature and higher-order aberrations, the study aims to assess the IOL's performance in terms of distance, intermediate, and near vision, and patient satisfaction. Its design features may offer favorable outcomes in these patients.
Eligibility criteria
Qualifiers
Age: 50 years and older.
Gender: Males and Females.
Bilateral cataracts
Bilateral implantation of Odyssey IOLs (toric and non-toric)
Disqualifiers
Established ocular pathology, including: glaucoma (except glaucoma suspects), uveitis, and clinically-significant retinal pathology affecting the macula (with visual acuity worse than 20/25) and/or any other ocular findings that may, in the opinion of the investigator, affect vision.
Uncontrolled diabetes.
Use of any systemic or topical drug known to interfere with visual performance.
Any concurrent infectious/non-infectious conjunctivitis, keratitis or uveitis.
Trial design
Treatments tested in this trial
- Odyssey intraocular lens
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Center For Sight
Lead sponsor
Sengi Clinical
Collaborator
Source ClinicalTrials.gov